Caroline Tillett - Mar 5, 2024 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Scientific Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Stock symbol
KVUE
Transactions as of
Mar 5, 2024
Transactions value $
$0
Form type
4
Date filed
3/7/2024, 06:27 PM
Previous filing
Feb 15, 2024
Next filing
Dec 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KVUE Restricted Stock Units Award $0 +12.3K $0.00 12.3K Mar 5, 2024 Common Stock 12.3K Direct F1, F2
transaction KVUE Stock Options Award $0 +111K $0.00 111K Mar 5, 2024 Common Stock 111K $19.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These units correspond 1 for 1 with the Company's common stock.
F2 This award vests in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date.